Trials / Recruiting
RecruitingNCT06659276
Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
Whole Body DWI Sequences As Compared with Standard FDG PET/CT in Patients with Simptomatic Multiple Myeloma
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 83 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the concordance of FDG PET/CT and total body DWI MRI sequences performed during staging and at the completion of therapy. Specifically, we will assess the positivity rates, both patient-based and lesion-based (total and by district), of the two methods during staging and at the completion of therapy. An interim analysis will be conducted comparing the two methods, followed by a final prognostic analysis.
Conditions
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2024-11-01
- Completion
- 2027-10-10
- First posted
- 2024-10-26
- Last updated
- 2024-10-26
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06659276. Inclusion in this directory is not an endorsement.